SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26.18
41.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 1SXP stock under the Base Case scenario is 34.28 EUR. Compared to the current market price of 27.66 EUR, SCHOTT Pharma AG & Co KgaA is Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
SCHOTT Pharma AG & Co KgaA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for 1SXP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
SCHOTT Pharma AG & Co KgaA
Balance Sheet Decomposition
SCHOTT Pharma AG & Co KgaA
Current Assets | 586m |
Cash & Short-Term Investments | 29.5m |
Receivables | 380.5m |
Other Current Assets | 176m |
Non-Current Assets | 813.1m |
Long-Term Investments | 84.9m |
PP&E | 679.7m |
Intangibles | 30.6m |
Other Non-Current Assets | 17.9m |
Current Liabilities | 415.6m |
Accounts Payable | 91m |
Accrued Liabilities | 53m |
Other Current Liabilities | 271.6m |
Non-Current Liabilities | 215.9m |
Long-Term Debt | 81.1m |
Other Non-Current Liabilities | 134.8m |
Earnings Waterfall
SCHOTT Pharma AG & Co KgaA
Revenue
|
948.6m
EUR
|
Cost of Revenue
|
-624.4m
EUR
|
Gross Profit
|
324.2m
EUR
|
Operating Expenses
|
-154.8m
EUR
|
Operating Income
|
169.4m
EUR
|
Other Expenses
|
-19m
EUR
|
Net Income
|
150.4m
EUR
|
Free Cash Flow Analysis
SCHOTT Pharma AG & Co KgaA
EUR | |
Free Cash Flow | EUR |
1SXP Profitability Score
Profitability Due Diligence
SCHOTT Pharma AG & Co KgaA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
SCHOTT Pharma AG & Co KgaA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
1SXP Solvency Score
Solvency Due Diligence
SCHOTT Pharma AG & Co KgaA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
SCHOTT Pharma AG & Co KgaA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
1SXP Price Targets Summary
SCHOTT Pharma AG & Co KgaA
According to Wall Street analysts, the average 1-year price target for 1SXP is 35.18 EUR with a low forecast of 31.31 EUR and a high forecast of 40.95 EUR.
Dividends
Current shareholder yield for 1SXP is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
SCHOTT Pharma AG & Co KgaA is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Mainz, Hessen. The company went IPO on 2023-09-28. SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The firm's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.
Contact
IPO
Employees
Officers
The intrinsic value of one 1SXP stock under the Base Case scenario is 34.28 EUR.
Compared to the current market price of 27.66 EUR, SCHOTT Pharma AG & Co KgaA is Undervalued by 19%.